Formation of conjugated metabolites after injection of (4-14C)17 alpha-hydroxyprogesterone into the umbilical vein of the human foetus at mid-pregnancy.
D015065:17-Hydroxycorticosteroids / Q000378:metabolism; D006907:17-alpha-Hydroxypregnenolone / Q000378:metabolism; D000311:Adrenal Glands / Q000378:metabolism; D002250:Carbon Radioisotopes; D002855:Chromatography, Thin Layer; D005260:Female; D005333:Fetus / Q000378:metabolism*; D005965:Glucuronates / Q000378:metabolism; D006801:Humans; D006854:Hydrocortisone / Q000378:metabolism; D006889:Hydroxycorticosteroids / Q000378:metabolism; D006908:Hydroxyprogesterones / Q000378:metabolism*; D066298:In Vitro Techniques; D007275:Injections, Intravenous; D007413:Intestinal Mucosa / Q000378:metabolism; D007664:Ketosteroids / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D008297:Male; D011247:Pregnancy; D011278:Pregnanes / Q000378:metabolism; D011279:Pregnanetriol / Q000378:metabolism; D013431:Sulfates / Q000378:metabolism; D014471:Umbilical Veins
D015065:17-Hydroxycorticosteroids; D002250:Carbon Radioisotopes; D005965:Glucuronates; D006889:Hydroxycorticosteroids; D006908:Hydroxyprogesterones; D007664:Ketosteroids; D011278:Pregnanes; D013431:Sulfates; D011279:Pregnanetriol; D006907:17-alpha-Hydroxypregnenolone; D006854:Hydrocortisone